'Standalone
net sales (including other operating income) of Bayer CropScience has declined
19.44% to Rs 791.50 crore. Operating
profit margin has declined from 20.95% to 12.20%, leading to 53.06% decline in
operating profit to Rs 96.60 crore. Raw
material cost as a % of total sales (net of stock adjustments) increased from
52.50% to 54.02%. Purchase of finished
goods cost fell from 7.03% to 3.20%.
Employee cost increased from 10.66% to 13.14%. Other expenses rose from 13.19% to
19.67%.
Other
income up 43% to Rs 29.6 crore.
PBIDT
fell 44.28% to Rs 126.2 crore. Provision
for interest fell 32.88% to Rs 4.9 crore.
Loan funds declined from Rs 73.50 crore as of 31 March 2023 to Rs 47.10
crore as of 31 March 2024. In...
Pleaselogin & subscribe to view the full report.
More Reports
-
(01-Mar-2025)
Foseco India
OP up 17%
-
(28-Feb-2025)
Schaeffler India
Maintains double digit revenue growth and stable OPM
-
(28-Feb-2025)
Sanofi India
OP up 18.78%
-
(28-Feb-2025)
KSB
Net up 33% largely on higher sales, higher OI and lower taxation
|
|